Let’s give breasts the attention they actually deserve.
Make annual screening a priority.
Understand your breast cancer risk.
Don't wait. The time to take action is now.
Breasts get so much attention, yet only 1 in 2 eligible women receive their annual screenings* that can catch breast cancer early, when it’s most treatable.
Early detection can save lives.
When breast cancer is caught early, patients have more than a 99% survival rate.† Although breast cancer risk varies for everyone, 40 is the recommended age for most women to start getting screened. If you’re over 40, prioritize your annual screening.
Understand your risk.
Under 40? It’s time to find out your breast cancer risk and then talk to your doctor about whether you should start screening earlier. You can’t always control the risk when it comes to breast cancer. But you can control how informed you are and how you act on that info.
Speak up, for breast’s sake.
From asking your doctor questions to spreading the word to your friends, self-advocacy starts with using your voice—for yourself and the people you care about.
Watch Our Videos
.
´
Give me the deets.
Together with Susan G. Komen®, NOVARTIS helped create the Alliance for Breast Cancer Policy, moving from attention to action by bringing together 25+ like-minded partners to improve outcomes in breast cancer through policy changes. The coalition's first priority is passing the Access to Breast Cancer Diagnosis (ABCD) Act, a crucial first step toward breaking down barriers to early detection and diagnosis.
Sometimes a mammogram spots something that doesn’t look like the rest, it’s a question mark. And questions need answers. If you’re at higher risk or the image doesn’t tell the full story, you might need an MRI or ultrasound to give a clearer picture into what’s going on.
But here's the catch, these additional exams often aren’t fully covered by insurance, translating into high out-of-pocket costs. The goal of the ABCD Act is to take steps to eliminate cost barriers for additional breast cancer screenings and follow-up diagnostic imaging, avoiding delays in diagnosis.
Get involved.
Show your support by sending a letter to your federal representatives and learning more about the Alliance.
Working together to change the numbers.
Novartis is working with our incredible partners on providing information about screenings, support, and other resources to help with questions you may have about breast cancer.
NOVARTIS is an Official Partner of the NFL. Learn how our partnership is empowering football fans everywhere to make proactive decisions about their health, understand screening guidelines, and build a playbook for a healthier future.
Congrats!
You're one step closer to prioritizing your breast health! Now, spread the word by visiting us on social—and get your crew to sign up, too.
Spread the word on social.
Remind the mothers, sisters, and loves in your life that their breast health matters.
You have our attention.
At NOVARTIS, we've been advancing science and innovations in breast cancer for over 30 years, and we know the importance of screening and early detection. That’s why NOVARTIS is providing science-backed information, resources, and support to help women take charge of their breast health. No matter where you are on your breast health journey, let us help you take the next step.
Helping you navigate testing and treatment options based on your breast cancer type.
Staying hopeful with a diagnosis of metastatic breast cancer.
* According to recent data, the chance of developing breast cancer from birth to death.
† Estimates include women aged ≥ 40 between 2017-2021.
‡ According to the latest data, nearly 100% of people live at least 5 years when cancer is detected early and in the localized stage.
† Estimates include women aged ≥ 40 between 2017-2021.
‡ According to the latest data, nearly 100% of people live at least 5 years when cancer is detected early and in the localized stage.